Korean J Gynecol Oncol.  2005 Sep;16(3):200-208.

Risk of malignancy index in the preoperative evaluation of ovarian masses

Affiliations
  • 1Department of Obstetrics and Gynecology, College of Medicine, Hanyang University, Seoul, Korea. kimkt@hanyang.ac.kr
  • 2Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea.

Abstract


OBJECTIVE
To assess the ability of risk of malignancy index (RMI) based on ultrasound findings, serum levels of CA 125, and menopausal status to discriminate between benign and malignant ovarian masses for preoperative screening.
METHODS
A retrospective study was conducted of 255 women with ovarian masses admitted for operation at the Department of Obstetrics and Gynecology, Hanyang University Hospital between 1999 and 2003. The sensitivity and specificity of serum levels of CA 125, ultrasound findings, and menopausal status were calculated both separately and combined into a RMI to diagnose malignancy.
RESULTS
There were significant preoperative differences of ultrasound findings, serum CA 125 level, serum CA 19-9 level, platelet count and menopausal status between benign and malignant ovarian masses (P<0.05). Using a cut-off value of 100 to indicate malignancy, the RMI gave a sensitivity of 81.7%, specificity of 81.9%. The RMI was more accurate in predicting malignancy than each one of its components measured individually.
CONCLUSION
The RMI is able to correctly discriminate between malignant and benign ovarian masses. This preoperative evaluation of women with ovarian masses is anticipated to help plan their management.

Keyword

Ovarian cancer; Ultrasound imaging; CA 125; Menopause

MeSH Terms

Female
Gynecology
Humans
Mass Screening
Menopause
Obstetrics
Ovarian Neoplasms
Platelet Count
Retrospective Studies
Sensitivity and Specificity
Ultrasonography
Full Text Links
  • KJGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr